Related by context. All words. (Click for frequent words.) 68 macrolide antibiotics 68 fluoroquinolone resistance 68 Clostridium difficile infections 67 candidemia 66 fluoroquinolone resistant 66 quinolone 66 serotype #A 66 tigecycline 66 chlamydial infection 66 nonvaccine 66 bacterial pneumonias 65 N. gonorrhoeae 65 MRSA colonization 65 mupirocin 65 quinolone resistant 65 invasive candidiasis 65 genital herpes infections 64 multidrug resistant organisms 64 Staphylococcus aureus infections 64 S.aureus 64 micafungin 64 pneumococcal infection 64 Bcr Abl mutations 64 C. diff infections 64 nitrofurantoin 64 candidiasis 64 hypervirulent strains 63 serogroup B 63 C. trachomatis 63 S aureus 63 protease inhibitors PIs 63 chlamydial 63 echinocandins 63 conjugate vaccines 63 Respiratory Syncytial Virus RSV 63 Bacteremia 63 varicella infection 63 antiangiogenic drugs 63 Neisseria gonorrhoeae 63 Multidrug resistant 62 immunosuppressed patients 62 acute respiratory tract infections 62 chronic HBV 62 multiresistant 62 skeletal metastases 62 needleless connectors 62 enterococcal 62 fluconazole resistant 62 meningococcal vaccines 62 imipenem 62 nosocomial infection 62 Candida infection 62 foodborne infections 62 rhinovirus infections 62 Human papillomavirus 62 CA MRSA infections 62 S. aureus infection 62 rituximab Rituxan 62 allogeneic HSCT 62 chronic periodontitis 62 PCV7 vaccine 62 serologic testing 62 combination antiretroviral therapy 62 KETEK 62 linezolid resistant 62 Candida infections 62 Vancomycin Resistant 62 biologic DMARD 61 Chlamydia infections 61 bacterial vaginosis BV 61 penicillins 61 methicillin susceptible Staphylococcus aureus 61 TMP SMX 61 antithrombotic agents 61 gonococcal 61 staphylococcal infections 61 Methicillin 61 beta lactam antibiotic 61 multidrug resistance 61 daptomycin 61 S. aureus isolates 61 immunosuppressive therapies 61 MenACWY 61 ESBLs 61 CellCept mycophenolate mofetil 61 cSSSIs 61 Ramoplanin 61 HCV infections 61 Enterococcus faecium 61 P aeruginosa 61 oesophageal adenocarcinoma 61 tick borne infections 61 hypervirulent strain 61 radezolid 61 cidofovir 61 Chlamydia trachomatis infection 61 antibiotic resistant bacterial infections 61 resistant Staphylococcus 61 Chlamydia infection 61 Helicobacter pylori H. pylori 61 transfusion transmitted 60 shingles herpes zoster 60 cytomegalovirus infection 60 invasive aspergillosis 60 FluCAM arm 60 rhinosinusitis 60 venous blood clots 60 ESBL producing E. coli 60 metastatic neuroendocrine tumors 60 antibiotic resistant strains 60 Altastaph 60 Chlamydia trachomatis 60 MRSA isolates 60 Aspergillus species 60 cytotoxic therapies 60 MenB 60 Kinoid 60 pneumococci 60 Pseudomonas aeruginosa infections 60 chlamydial infections 60 Staph aureus 60 Lactobacillus GG 60 empiric therapy 60 sulfamethoxazole 60 S. aureus bloodstream infections 60 quinolones 60 Bloodstream infections 60 Enteroviruses 60 carbapenem resistant 60 Clostridium difficile C. difficile 60 HeFH 60 resistant organisms 60 bacterial sepsis 60 staphylococcal infection 60 bacterium Neisseria meningitidis 60 tract infections 60 delafloxacin 60 malignant lymphomas 60 torezolid 60 respiratory viral infections 60 E. faecalis 60 strep infections 60 S. aureus infections 60 HIV HCV coinfected 60 cervical vaginal 60 hepatitis B infection 60 NNRTI resistant virus 60 generation cephalosporins 60 viral respiratory infections 60 griseofulvin 60 opportunistic pathogens 60 Fluoroquinolones 60 thalidomide Thalomid 60 immunocompromised patients 60 relapsed MM 60 herpes labialis 60 H pylori 60 gonorrhoeae 59 carbapenem 59 N. meningitidis 59 probiotic supplementation 59 latent tuberculosis TB 59 S. aureus colonization 59 vaginal candidiasis 59 MYCAMINE 59 ano genital warts 59 intra abdominal infections 59 EBV infection 59 GABHS 59 gonococcal infection 59 bacterial respiratory infections 59 malignant ascites 59 antimicrobial prophylaxis 59 vaccine Menveo 59 spectrum beta lactamases 59 nonnucleoside reverse transcriptase inhibitors 59 hyper virulent strain 59 hematological toxicity 59 Gleevec imatinib mesylate 59 ertapenem 59 BI/NAP#/# 59 Bacillus Calmette Guerin BCG 59 HBV vaccination 59 aureus infections 59 hematologic abnormalities 59 Methicillin resistant S. aureus 59 quinolone antibiotics 59 antineoplastic 59 transaminase elevations 59 immunocompetent patients 59 vancomycin resistant 59 endometrial hyperplasia 59 S. aureus bacteremia 59 mTOR inhibitors 59 beta lactam antibiotics 59 epithelial tumors 59 nonsevere 59 pneumococcal serotypes 59 Pneumocystis carinii pneumonia 59 coinfection 59 HER2 overexpression 59 Tindamax R 59 solithromycin 59 herpes zoster vaccine 59 Cellcept 59 Cdiff 59 Opportunistic infections 59 Alferon LDO 59 P. falciparum malaria 59 Mycoplasma pneumoniae 59 follicular lymphoma FL 59 methicillin resistant S. aureus 59 vancomycin resistant enterococci VRE 59 G6PD deficiency 59 resistant S. aureus 59 Chronic Prostatitis 59 lymphoid tumors 59 resistant Staphylococcus aureus 59 systemic fungal infections 59 null responder 59 atopic disease 59 Cytomegalovirus CMV 59 Rimantadine 59 #I TM# 59 corticosteroid therapy 59 nosocomial pneumonia 59 Helicobacter pylori infection 59 protease inhibitor PI 59 Enterobacter cloacae 59 BARACLUDE ® 59 neuro developmental disorders 59 thromboembolic disease 59 NNRTIs 59 H Pylori 59 antibiotic methicillin 59 herpes zoster shingles 59 antimicrobial resistant 59 Bacterial infection 59 MRSA bloodstream infection 59 ALK inhibitors 59 ocular toxicity 59 causative pathogen 59 Aortic stenosis 59 hypocalcaemia 59 intravenous bisphosphonates 59 imatinib resistance 59 chemotherapy induced neutropenia 59 efalizumab 59 gastrointestinal stromal tumors GIST 59 antiangiogenesis 59 adrenal suppression 59 multidrug resistant MDR 59 Beta lactamase 59 Cryptococcus neoformans 59 multidrug resistant strains 59 neutropenic 59 rheumatic disorders 59 influenzalike illness 59 quadrivalent vaccine 59 immuno compromised patients 59 macrolide resistant 59 sodium stibogluconate 59 Arranon 59 genital ulcers 58 methicillin resistant 58 P. acnes 58 Hepatotoxicity 58 atypical antipsychotic medications 58 ALT flares 58 P. vivax malaria 58 BSIs 58 Vesivirus 58 PCV7 58 JNJ Q2 58 MRSA methicillin resistant 58 Hypotension 58 rheumatologic 58 S. pneumoniae 58 Febrile neutropenia 58 C. diff infection 58 resistant microorganisms 58 susceptible isolates 58 poliovirus vaccine 58 CMV infection 58 rotaviruses 58 dermatophytes 58 invasive fungal infections 58 capsular polysaccharide 58 haematological malignancies 58 TroVax ® 58 bacteraemia 58 indinavir 58 congenital CMV infection 58 hypersensitivity allergic reactions 58 prokinetic 58 chancroid 58 swine dysentery 58 C difficile infection 58 Clostridium difficile infection 58 postexposure prophylaxis 58 TNF alpha inhibitor 58 pertussis vaccines 58 vaginal yeast infections 58 MDR strains 58 samalizumab 58 Candida species 58 macrolide 58 orchitis 58 therapeutic armamentarium 58 PHPT 58 antifungal medications 58 nosocomial hospital 58 CP CPPS 58 K#R [002] 58 vancomycin resistant enterococci 58 nonbacterial 58 Panton Valentine leukocidin PVL 58 PPSV# 58 IgM antibodies 58 eosinophilic pneumonia 58 invasive fungal 58 Epstein Barr Virus EBV 58 oseltamivir resistant 58 Staphylococcus aureus MRSA 58 pharmacokinetic interactions 58 HAV infection 58 Molluscum Contagiosum 58 mediastinitis 58 nucleoside analogues 58 oropharyngeal cancers 58 HPV-#/# 58 hepatic toxicity 58 gonococcal infections 58 superantigens 58 opportunistic fungal infections 58 malignant neoplasms 58 omnicef 58 cervical HPV 58 Antibiotic resistance 58 SSTIs 58 candida infections 58 fusion enhancers 58 H#N# Swine flu 58 pestis 58 respiratory pathogens 58 toxoid 58 Staph aureus infections 58 vitamin D inadequacy 58 Nosocomial 58 human rhinovirus HRV 58 amphotericin B 58 myopathy rhabdomyolysis 58 acute rheumatic fever 58 trivalent inactivated influenza 58 benzimidazole 58 riociguat 58 MRSAid TM 58 Aviptadil 58 Streptococcus pneumonia 58 infliximab Remicade 58 7 valent pneumococcal 58 CMV infections 58 Hospital Acquired Infections 58 severe asthma exacerbations 58 anterior uveitis 58 Tamiflu resistant strains 58 NNRTI resistance 58 allergic rhinitis hay fever 58 Alferon N 58 diabetic kidney 58 nosocomial 58 trichomonas 58 ocular allergy 58 antiepileptics 58 simplex virus 58 microbiological eradication 58 coagulase negative 58 Immune responses 58 neuro psychiatric disorders 58 amoxicillin clavulanate 58 prostaglandin analogues 58 cephalosporins 58 viral titers 58 adamantane resistance 58 myelodysplastic myeloproliferative diseases 58 immune reconstitution syndrome 58 CRBSI 58 biphosphonates 58 BCR ABL mutations 58 Acute Bacterial Sinusitis ABS 58 gastric adenocarcinoma 58 fluoroquinolone antibiotic 58 acetonide FA 58 Chlamydia psittaci 58 rifamycins 58 multidrug resistant 58 tuberculin skin testing 58 suppressive therapy 57 anti CD3 antibody 57 anti angiogenic agents 57 diaper dermatitis 57 Tigecycline 57 antibiotic resistant MRSA 57 Trichomonas vaginalis 57 etiologic agent 57 acute GvHD 57 dentinal hypersensitivity 57 Vidaza azacitidine 57 Onychomycosis 57 anthelmintics 57 beta interferons 57 calcineurin inhibitors 57 RSV infections 57 C. difficile infections 57 P vivax 57 latent tuberculosis infection 57 Antibacterials 57 antiangiogenic agents 57 Anidulafungin 57 trastuzumab Herceptin ® 57 ESBL producing 57 genital wart 57 co trimoxazole 57 neoplasias 57 hemorrhagic cystitis 57 severely immunocompromised patients 57 antibiotic azithromycin 57 Fludarabine 57 recombinant interferon 57 pneumococcal vaccination 57 post surgical adhesions 57 VivaGel TM 57 immunomodulatory therapy 57 chronic hepatitis cirrhosis 57 streptococcal infections 57 antibiotic vancomycin 57 antibiotic prophylaxis 57 virus HBV 57 C conjugate vaccine 57 NRTI resistance 57 nonmelanoma skin cancers 57 neovascular diseases 57 monoclonal antibody therapies 57 genital ulcer 57 topical antimicrobial 57 Twinrix 57 ReA 57 NPM1 57 influenza antiviral medications 57 haematopoietic 57 azole 57 resistant Staphylococcus aureus MRSA 57 PREVENAR 57 BEXXAR Therapeutic Regimen 57 ALI ARDS 57 pseudomembranous colitis 57 diphtheria pertussis whooping cough 57 vivo potency 57 clonal expansion 57 squamous cell lung cancer 57 reemerging infectious diseases 57 P. aeruginosa infections 57 Saccharomyces boulardii 57 CDAD 57 zoonotic pathogens 57 palivizumab 57 immuno modulatory 57 Evoltra ® 57 allergen immunotherapy 57 neutropenic patients 57 erythromycin resistant 57 bronchodilatory 57 oxacillin 57 cancerdefine 57 intradermal vaccine 57 T. pallidum 57 carotid plaques 57 allograft rejection 57 Human Papilloma Virus 57 anti androgens 57 Escherichia coli O# 57 coagulase negative staphylococci 57 lichen planus 57 hypereosinophilic syndrome 57 chlamydia infections 57 antiresorptive 57 CCR5 tropic 57 Aspergillosis 57 Infusion Reactions Severe 57 Merck Isentress 57 Human Papilloma Virus HPV 57 gastrointestinal stromal tumors GISTs 57 endophthalmitis 57 bacterial keratitis 57 pemphigus vulgaris 57 Enterobacteriaceae 57 Staphylococcal 57 mycophenolate 57 meningococcus 57 Smallpox vaccine 57 MGUS 57 SSc patients 57 transgenic rats 57 macrolides 57 anagrelide 57 vivax 57 meticillin resistant Staphylococcus aureus 57 bacteriuria 57 Ceftaroline 57 Staphylococcus infections 57 genital HSV 57 systemic toxicity 57 etiological agent 57 Antibiotic resistant 57 Streptococcus pyogenes 57 histone deacetylase HDAC 57 MRSA Clostridium difficile 57 mitochondrial toxicity 57 polysaccharide vaccines 57 Herpes Simplex Virus 57 Xifaxan rifaximin 57 tetravalent vaccine 57 Removab 57 CIN3 57 Poliovirus 57 Dalbavancin 57 mycobacterial infections 57 extramedullary 57 sexually transmitted HPV 57 campylobacter infections 57 Azilect ® 57 COPD exacerbations 57 cutaneous squamous cell carcinoma 57 somatostatin analogs 57 meningococcal conjugate vaccine 57 HIV coinfected 57 primary hyperparathyroidism 57 baumannii 57 Velcade bortezomib 57 vaccine serotypes 57 K#N 57 antiplatelet therapies 57 Escherichia coli Klebsiella pneumoniae 57 Skin rashes 57 enterovirus infection 57 S OIV 57 im peramivir 57 orthopoxvirus 57 Amantadine 56 sputum cultures 56 atypical femur fractures 56 meningococcal conjugate 56 SNT-MC#/idebenone 56 hepatorenal syndrome 56 Genetic mutation 56 C.difficile infections 56 MenC 56 causative pathogens 56 inhibits protein synthesis 56 parasitemia 56 genital ulcer disease 56 indwelling catheters 56 prednisone prednisolone 56 MAGE A3 ASCI 56 molecularly targeted therapies 56 recurrent genital herpes 56 respiratory gastrointestinal 56 resistant gonorrhea 56 cervicitis 56 empiric treatment 56 B streptococcal 56 acinetobacter 56 Babesiosis 56 immunoregulation 56 gastrointestinal dysfunction 56 Gleevec resistant 56 esophageal candidiasis 56 antibiotic resistant microorganisms 56 neuroendocrine cancers 56 clostridium 56 DVT PE 56 pneumoniae 56 BARACLUDE resistance 56 fungus Fusarium 56 valacyclovir Valtrex 56 complete cytogenetic response 56 fusidic acid 56 Staphylococci 56 Propionibacterium 56 nonallergic rhinitis 56 Thyroid nodules 56 hepatotoxic 56 methicillin resistant MRSA 56 histological subtype 56 inhaled bronchodilators 56 anemias 56 Interferon beta 56 eculizumab therapy 56 pneumococcal infections 56 NAbs 56 menadione 56 alpha interferons 56 hematological malignancy 56 granulomatous 56 H. influenzae 56 Raptiva ® 56 external genital lesions 56 immunopathology 56 Heavy menstrual bleeding 56 myeloproliferative diseases 56 germline mutations 56 ketolide antibiotic 56 Onconase 56 OHR/AVR# 56 H#Y 56 adenovirus infections 56 congenital CMV 56 allergic dermatitis 56 pneumocystis pneumonia 56 Genital herpes 56 postexposure 56 nontuberculous mycobacteria 56 Plasmodium infection 56 non metastatic osteosarcoma 56 oxytetracycline 56 cephalosporin 56 monogenic 56 Magnesium deficiency 56 herpes infections 56 secondary hyperparathyroidism 56 BMPR2 56 VivaGel ™ 56 histologic subtype 56 SPRYCEL ® 56 Motavizumab 56 LCMV infection 56 ileitis 56 kidney urologic 56 Molluscum 56 Drug resistant strains 56 Human cl 56 Sudhir Agrawal D.Phil 56 Anaplasma 56 cervical lesions 56 Leukemias 56 Staphylococcus epidermidis 56 Trichinella 56 Pneumococcus 56 canakinumab 56 HSV1 56 staphylococci 56 USA# strain 56 NMIBC 56 pathophysiological processes 56 rhinovirus infection 56 chronic GVHD 56 lupus anticoagulant 56 protozoal 56 inactivated influenza vaccine 56 sJIA 56 Pasteurella multocida 56 VZV 56 bacteria Pseudomonas 56 coinfections 56 PML progressive multifocal 56 atopic dermatitis AD 56 fungal keratitis 56 ADAMTS# 56 C trachomatis 56 CYT# potent vascular disrupting 56 ATL/TV# 56 HBV vaccine 56 serious pneumococcal infections 56 anaerobic spore forming 56 overactive bladder syndrome 56 Chlamydia pneumoniae 56 Zolinza 56 antiplatelet medications 56 C. sordellii 56 nociceptive pain 56 Latent TB 56 Nosocomial infections 56 perinatally 56 pharmacologic intervention 56 reproductive tract infections 56 Vancomycin resistant 56 RSV prophylaxis 56 dyslipidemias 56 immunocompetent 56 Salmonella spp 56 endotoxemia 56 ciclosporin 56 Enbrel Humira 56 G CSFs 56 rFVIIa 56 premalignant lesions 56 WNV encephalitis 56 Cloretazine 56 metabolic abnormality 56 tetanus diphtheria vaccines 56 dysmenorrhoea 56 epigenetic therapies 56 viral conjunctivitis 56 Clostridium difficile associated 56 Clostridium difficile C. diff 56 HCV antibody 56 IVIG therapy 56 vaginal flora 56 disease CDAD 56 tuberculous 56 cyclophilin inhibitors 56 subcutaneous immunoglobulin 56 β blockers 56 chlamydia infection 56 b Hib 56 acid reflux heartburn 56 glycopeptide 56 vaginal lesions 56 Streptomycin 56 monoclonal antibody MAb 56 vaccinees 56 mycosis 56 recurrent venous thromboembolism 56 keloid formation 56 pneumococcal strains 56 Staphylococcus aureus MSSA 56 G#DT 56 phototoxicity 56 cutaneous lupus 56 Salmonella typhi 56 Mucositis 56 enteric bacteria 56 cIAI 56 Norvir ritonavir 56 PROCHYMAL 56 TEAEs 56 whooping cough pertussis 56 dexrazoxane 56 invasive Hib 56 Gatifloxacin 56 CCR5 receptor antagonist 56 papilloma virus 56 Havrix 56 intracranial hemorrhage ICH 56 Respiratory syncytial virus RSV 56 Ixiaro 56 H. pylori eradication 56 MRSA strains 56 Zavesca R 56 viral subtypes 56 Progressive Multifocal Leukoencephalopathy 56 gastro intestinal diseases 56 ocular infections 56 NMDA antagonists 56 syndromic 56 acute leukemias 55 nucleotide analog 55 basal cell carcinoma BCC 55 prostate cancer CaP 55 HbF 55 meningococcal serogroup B 55 tardive dyskinesia TD 55 polycythemia vera essential thrombocythemia 55 GnRH agonists 55 prospectively enrolled 55 hMPV 55 hyoscyamine 55 haemolytic anemia 55 GIST tumors 55 tumorigenicity 55 subclinical disease 55 Bacterial Vaginosis 55 methicillin resistant staph aureus 55 receptor tyrosine kinase inhibitor 55 atopic eczema 55 HCV infection 55 Synovial sarcoma 55 Golimumab 55 Bordetella pertussis 55 enteric pathogens 55 C. difficile infection 55 antitumor efficacy 55 Faropenem 55 nifurtimox 55 enterotoxigenic E. coli 55 proteasome inhibitor 55 leiomyomas 55 diabetic gastroparesis 55 cerebral vasospasm 55 Periodontitis 55 HBeAg positive patients 55 Inflammatory Diseases 55 Dengue Hemorrhagic Fever 55 conjugate vaccine 55 IgG4 55 hematological disorders 55 hyperprolactinemia 55 Campylobacter infections 55 Neisseria meningitides 55 sore throats colds 55 thyroid carcinoma 55 intensive statin therapy 55 perinatal transmission 55 somatostatin analogues 55 beta estradiol 55 causative agents 55 chronic prostatitis 55 Listeria infections 55 atypical hemolytic uremic syndrome 55 antigen sparing 55 Influenza vaccination 55 beta lactamases 55 CD4 + T lymphocytes 55 serogroups 55 methicillin resistance 55 nephrotoxicity 55 Streptococcus pneumoniae 55 drug ISA# 55 immunosuppressive regimens 55 C diff infections 55 Candida glabrata 55 skeletal sarcomere activator 55 resistant pathogens 55 Endometrial cancer 55 Acinetobacter baumannii 55 BCL#A 55 severe hyperbilirubinemia 55 ocular allergies 55 bactericidal activity 55 Eisenmenger syndrome 55 HBV infection 55 cytostatic 55 T. vaginalis 55 leukotriene receptor antagonist 55 Actinic Keratosis 55 resistant superbugs 55 AGHD 55 epiglottitis 55 plasma kallikrein 55 herpetic keratitis 55 valent pneumococcal conjugate vaccine 55 Iron deficiency anemia 55 Antibiotic resistant infections 55 atopic disorders 55 coagulation disorders 55 antibiotic resistant pathogens 55 HuLuc# 55 EGFR tyrosine kinase inhibitors 55 antiviral therapies 55 WNV infections 55 Entamoeba histolytica 55 antiangiogenic agent 55 Toxicities 55 tuberculosis hepatitis B 55 neuropsychiatric diseases 55 antiandrogens 55 vidofludimus 55 antibiotic overuse 55 erythropoietic 55 erythema nodosum 55 abnormal vaginal bleeding 55 genotypic resistance 55 neuraminidase inhibitor 55 Respiratory Virus 55 chromosomal rearrangement 55 aureus MRSA 55 S. Typhimurium 55 HCV protease inhibitors 55 oncogenic HPV types 55 immune modulating 55 thrombotic complications 55 ROTARIX 55 IgG2 55 pH#N# 55 Lactobacillus reuteri 55 PREVNAR 55 Pelvic Inflammatory Disease 55 C diff infection 55 HBV infections 55 rhITF 55 pharyngitis tonsillitis 55 systemic corticosteroid 55 Community Acquired Pneumonia 55 Clostridia 55 R5 tropic 55 biosimilar versions 55 HPV subtypes 55 Inflammatory diseases 55 Streptococcus pneumoniae Haemophilus influenzae 55 Adhibit 55 cSSSI 55 artemisinins 55 Surgical resection 55 multimodality therapy 55 Moraxella catarrhalis 55 bacteria Neisseria meningitidis 55 PASI scores 55 molluscum contagiosum 55 intravascular hemolysis 55 C. perfringens 55 Epidermal Growth Factor Receptor 55 hematologic toxicity 55 M. catarrhalis 55 HER2 positive cancers 55 K ras mutations 55 effector function 55 drug eluting coronary stents 55 KRAS oncogene 55 oral thrush 55 cefprozil 55 anti angiogenic therapy 55 Menactra vaccine 55 CYP #A# 55 antibiotics metronidazole 55 B. burgdorferi 55 acute rhinosinusitis 55 chronic HBV infection 55 pharmacogenetic testing 55 glioblastoma tumor 55 Vitamin D insufficiency 55 Pneumocystis 55 Abscesses 55 PDE4 inhibitors 55 salmonellae 55 antibiotic prescribing 55 HBeAg negative 55 Tamiflu Relenza 55 polytherapy 55 Alequel 55 Vitamin B# deficiency 55 β lactam 55 antifungal agent 55 constipation OIC 55 Xerostomia 55 rebleeding 55 pancreatic insufficiency 55 Salmonella Campylobacter 55 MDR tuberculosis 55 ChronVac C ® 55 IGRAs 55 H.pylori 55 microbial biofilms 55 cryptococcosis 55 Ygiene 55 CKD ND 55 neuro degenerative disorders 55 Candidiasis 55 streptococcal disease 55 DESs 55 invasive pneumococcal infections 55 Recurrences 55 antiviral prophylaxis 55 malarial infections 55 Pafuramidine 55 atherothrombotic disease 55 adeno associated viruses 55 immunosuppressive agents 55 chemoprevention trials 55 urologic diseases 55 varicella zoster virus VZV 55 abdominal adiposity 55 pneumococcal immunization 55 pneumocystis 55 TNF α 55 HIB vaccine 55 Vaginal gel 55 Urinary tract 55 Sildenafil Viagra 55 ß blockers 55 CMV disease 55 recombinant hepatitis B 55 seroprotection 55 falciparum malaria 55 Methicillin resistant 55 Chronic HCV 55 bacterial colonization 55 Hepatitis C infections 55 clade B 55 virus RSV 55 kanamycin 55 hepatitis C genotype 55 methicillin resistant staph 55 herpes simplex encephalitis 55 gastric carcinoma 55 seminoma 55 PEDF 55 Pneumococcal vaccine 55 osteosarcomas 55 Lipsovir ® 55 hepatitis C infection 55 Monoclonal antibody 55 antibiotic resistant Staphylococcus aureus 55 trimethoprim 55 rhIL 7 55 Respiratory syncytial virus 55 Herpes virus 55 nasal antihistamine 55 Diaper rash 55 Prostatitis